Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reviews

Management of portal hypertensive gastropathy and other bleeding

Woo Jin Chung

Clin Mol Hepatol. 2014;20(1):1-5. Published online March 26, 2014

Web of Science 7 Crossref 4

DOI: https://doi.org/10.3350/cmh.2014.20.1.1

Hepatic venous pressure gradient: clinical use in chronic liver disease

Ki Tae Suk

Clin Mol Hepatol. 2014;20(1):6-14. Published online March 26, 2014

Web of Science 102 Crossref 96

DOI: https://doi.org/10.3350/cmh.2014.20.1.6

Editorial

Do cirrhotic patients with a high MELD score benefit from TIPS?

Won Hyeok Choe

Clin Mol Hepatol. 2014;20(1):15-17. Published online March 26, 2014

Web of Science 4 Crossref 3

DOI: https://doi.org/10.3350/cmh.2014.20.1.15

Original Articles

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data

Hyung Ki Kim, Yoon Jun Kim, Woo Jin Chung, Soon Sun Kim, Jae Jun Shim, Moon Seok Choi, Do Young Kim, Dae Won Jun, Soon Ho Um, Sung Jae Park, Hyun Young Woo, Young Kul Jung, Soon Koo Baik, Moon Young Kim, Soo Young Park, Jae Myeong Lee, Young Seok Kim

Clin Mol Hepatol. 2014;20(1):18-27. Published online March 26, 2014

Web of Science 21 Crossref 20

DOI: https://doi.org/10.3350/cmh.2014.20.1.18

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Jee Eun Yang, Eunji Park, Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eunsil Yu, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2014;20(1):28-37. Published online March 26, 2014

Web of Science 2 Crossref 2

DOI: https://doi.org/10.3350/cmh.2014.20.1.28

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2014;20(1):38-46. Published online March 26, 2014

Web of Science 32 Crossref 31

DOI: https://doi.org/10.3350/cmh.2014.20.1.38

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2014;20(1):47-55. Published online March 26, 2014

Web of Science 5 Crossref 2

DOI: https://doi.org/10.3350/cmh.2014.20.1.47

Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study

Nese Demirturk, Tuna Demirdal

Clin Mol Hepatol. 2014;20(1):56-60. Published online March 26, 2014

Web of Science 2 Crossref 1

DOI: https://doi.org/10.3350/cmh.2014.20.1.56

Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US

Ji Hye Min, Hyo Keun Lim, Sanghyeok Lim, Tae Wook Kang, Kyoung Doo Song, Seo-youn Choi, Hyunchul Rhim, Min Woo Lee

Clin Mol Hepatol. 2014;20(1):61-70. Published online March 26, 2014

Web of Science 51 Crossref 48

DOI: https://doi.org/10.3350/cmh.2014.20.1.61

Case Reports

Allopurinol-induced DRESS syndrome mimicking biliary obstruction

Hyung Gyu Choi, Junsu Byun, Chae Ho Moon, Jong Ho Yoon, Ki Young Yang, Su Cheol Park, Chul Ju Han

Clin Mol Hepatol. 2014;20(1):71-75. Published online March 26, 2014

Web of Science 6 Crossref 7

DOI: https://doi.org/10.3350/cmh.2014.20.1.71

Improved severe hepatopulmonary syndrome after liver transplantation in an adolescent with end-stage liver disease secondary to biliary atresia

Tae Jun Park, Keun Soo Ahn, Yong Hoon Kim, Hyungseop Kim, Ui Jun Park, Hyoung Tae Kim, Won Hyun Cho, Woo-Hyun Park, Koo Jeong Kang

Clin Mol Hepatol. 2014;20(1):76-80. Published online March 26, 2014

Web of Science 3 Crossref 3

DOI: https://doi.org/10.3350/cmh.2014.20.1.76

Liver Pathology

Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy

An Na Seo, Haeryoung Kim

Clin Mol Hepatol. 2014;20(1):81-84. Published online March 26, 2014

Web of Science 22 Crossref 21

DOI: https://doi.org/10.3350/cmh.2014.20.1.81

Liver Imaging

Sonography of hepatic hemangioma accompanied by arterioportal shunt

Sang Hyun Choi, Kyoung Won Kim, Gil Sun Hong, So Jung Lee, So Yeon Kim, Jong Seok Lee, Hyoung Jung Kim

Clin Mol Hepatol. 2014;20(1):85-87. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.85

Viewed By 5342	MAFLD: How is it different from NAFLD?
Viewed By 5103	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4673	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4655	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4497	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 253	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 204	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 139	MAFLD: How is it different from NAFLD?
Cited By 114	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Previous issues